Status:
RECRUITING
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Infectious Diseases Models for Innovative Therapies center
Conditions:
Bronchiolitis
Eligibility:
All Genders
1-12 years
Brief Summary
Acute bronchiolitis is a common disease in children under the age of two, caused mainly by the respiratory syncytial virus (RSV). Furthermore, given the same medical history, it is still very difficul...
Eligibility Criteria
Inclusion
- Infants \<12 months
- With bronchiolitis during RSV epidemic season
- No chronic illness
- No bronchiolitis medical history
- Signed consent from parents or legal guardians
Exclusion
- Chronic respiratory illness
- Medical history of bronchiolitis or newborn asthma
- Treatment with immunosuppressants
- Patient with no social security affiliation
Key Trial Info
Start Date :
December 6 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06161285
Start Date
December 6 2024
End Date
April 1 2026
Last Update
February 26 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
APHP, Antoine Béclère Hospital
Clamart, France, 92140
2
AP-HP,Raymond Poincaré Hospital
Garches, France, 92380
3
Réanimation médico-chirurgicale Necker
Paris, France, 750